These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6972180)

  • 21. Identification and partial characterization of multiple forms of biologically active EGF in rat milk.
    Schaudies RP; Grimes J; Wray HL; Koldovský O
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G1056-61. PubMed ID: 2260661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive two-site enzyme immunoassay for human epidermal growth factor (urogastrone).
    Hayashi K; Nomoto H; Kurobe M; Nishimuro S; Hiratani H; Furukawa S
    Biochem Int; 1985 Jun; 10(6):839-45. PubMed ID: 3899115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and structure of urogastrone and its relationship to epidermal growth factor.
    Gregory H
    Nature; 1975 Sep; 257(5524):325-7. PubMed ID: 1161035
    [No Abstract]   [Full Text] [Related]  

  • 24. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of a low and a high molecular weight form of epidermal growth factor from rat urine.
    Nexø E; Jørgensen PE; Thim L; Roepstorff P
    Biochim Biophys Acta; 1990 Mar; 1037(3):388-93. PubMed ID: 2310752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eye-derived growth factor from retina and epidermal growth factor are immunologically distinct and bind to different receptors on human foreskin fibroblasts.
    Plouët J; Barritault D; Courtoirs Y; Ladda R
    FEBS Lett; 1982 Jul; 144(1):85-8. PubMed ID: 6980797
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives.
    Hollenberg MD; Gregory H
    Mol Pharmacol; 1980 May; 17(3):314-20. PubMed ID: 6248761
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidermal growth factor-urogastrone].
    Zhang JF; Guo YS
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):151-6. PubMed ID: 6333725
    [No Abstract]   [Full Text] [Related]  

  • 29. Is epidermal growth factor present in human blood? Interference with the radioreceptor assay for epidermal growth factor.
    Bowen-Pope DF; Ross R
    Biochem Biophys Res Commun; 1983 Aug; 114(3):1036-41. PubMed ID: 6311192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of epidermal growth factor with monoclonal antibody.
    Akai K; Goto M; Ueda M
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1721-7. PubMed ID: 3487391
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioimmunoassay of human epidermal growth factor (urogastrone).
    Starkey RH; Orth DN
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1144-53. PubMed ID: 304067
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidermal cell derived factor (EDF): partial purification and characterization.
    Eisinger M; Flick RB; Bizik J; Arita Y
    Prog Clin Biol Res; 1991; 365():375-89. PubMed ID: 1862145
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of growth factors derived from the rat ventral prostate.
    Jacobs SC; Story MT; Sasse J; Lawson RK
    J Urol; 1988 May; 139(5):1106-10. PubMed ID: 3258927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man.
    Hirata Y; Moore GW; Bertagna C; Orth DN
    J Clin Endocrinol Metab; 1980 Mar; 50(3):440-4. PubMed ID: 6965677
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification by reverse-phase high-performance liquid chromatography of an epidermal growth factor-dependent transforming growth factor.
    Anzano MA; Roberts AB; Smith JM; Lamb LC; Sporn MB
    Anal Biochem; 1982 Sep; 125(1):217-24. PubMed ID: 6983313
    [No Abstract]   [Full Text] [Related]  

  • 36. Presence of epidermal growth factor in human tears.
    Ohashi Y; Motokura M; Kinoshita Y; Mano T; Watanabe H; Kinoshita S; Manabe R; Oshiden K; Yanaihara C
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1879-82. PubMed ID: 2788149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rapid isolation of highly purified epidermal growth factor by reverse-phase liquid chromatography].
    Ivashchenko IuD; Osipova LA; Gut IT; Garmanchuk LV
    Eksp Onkol; 1985; 7(6):47-9. PubMed ID: 3878774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.
    Hirata Y; Orth DN
    J Clin Endocrinol Metab; 1979 Apr; 48(4):673-9. PubMed ID: 311774
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation and purification of an end to end coupled mEGF-dextran conjugate.
    Zhao Q; Gottschalk I; Carlsson J; Arvidsson LE; Oscarsson S; Medin A; Ersson B; Janson JC
    Bioconjug Chem; 1997; 8(6):927-34. PubMed ID: 9404668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and properties of a type beta transforming growth factor from bovine kidney.
    Roberts AB; Anzano MA; Meyers CA; Wideman J; Blacher R; Pan YC; Stein S; Lehrman SR; Smith JM; Lamb LC
    Biochemistry; 1983 Dec; 22(25):5692-8. PubMed ID: 6607069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.